Browsing byAuthorLucchetta, RC
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2017-03-01 | Diethylpropion and mazindol: An end to the discussion? | Lucchetta, RC; Riveros, BS; Pontarolo, R; Radominski, RB; Otuki, MF; Fernandez-Llimos, F; Correr, CJ |
2018-05-01 | IMMUNOMODULATORS AND IMMUNOSUPPRESSANTS FOR PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS | Lucchetta, RC; Tonin, FS; Borba, HH; Leonart, LP; Ferreira, VL; Bonetti, AF; Riveros, BS; Becker, J; Pontarolo, R; Fernandez-Llimos, F; Wiens, A |
2019-10-01 | Safety outcomes of disease-modifying therapies for relapsing–remitting multiple sclerosis: A network meta-analysis | Lucchetta, RC; Leonart, LP; Becker, J; Pontarolo, R; Fernandez-Llimós, F; Wiens, A |
2017-01-01 | Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients | Lucchetta, RC; Riveros, BS; Pontarolo, R; Radominski, RB; Otuki, MF; Fernandez-Llimos, F; Correr, CJ |
2018-01-01 | Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients (vol 72, pg 317, 2017) | Lucchetta, RC; Riveros, BS; Pontarolo, R; Radominski, RB; Otuki, MF; Fernandez-Llimos, F; Correr, CJ |